Dow Up0.26% Nasdaq Down1.07%

Cumberland Pharmaceuticals, Inc. (CPIX)

-NasdaqGS
5.00 0.14(2.72%) Sep 15, 3:58PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 32,027   48,851   51,143  
Cost of Revenue5,439  5,046  5,363  
Gross Profit 26,588   43,805   45,780  
Operating Expenses
Research Development5,616  5,095  5,028  
Selling General and Administrative23,878  29,385  30,247  
Non Recurring -   -   -  
Others896  506  655  
Total Operating Expenses -   -   -  
Operating Income or Loss (3,801) 8,818   9,849  
Income from Continuing Operations
Total Other Income/Expenses Net230  305  211  
Earnings Before Interest And Taxes(3,571)9,123  10,060  
Interest Expense103  72  353  
Income Before Tax(3,674)9,051  9,707  
Income Tax Expense(1,523)3,245  4,080  
Minority Interest47  36  31  
Net Income From Continuing Ops(2,105)5,842  5,658  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (2,105) 5,842   5,658  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (2,105) 5,842   5,658  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.